PDS Biotechnology

+$0.10 (+0.95%) Today

+$0.10 (+0.94%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.

About PDSB

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.

CEO

Frank K. Bedu-Addo

Employees

Headquarters

Princeton, New Jersey

Founded

2005

PDSB Key Statistics

Market Cap

294.20M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

497.31K

High Today

$10.72

Low Today

$10.27

Open Price

$10.61

Volume

250.52K

52 Week High

$13.48

52 Week Low

$1.84

Analyst Ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

PDSB Earnings

-$0.39

-$0.26

-$0.13

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 12, Pre-Market